PLRZ Stock Summary and Trading Ideas (Polyrizon Ltd. - | NASDAQ:PLRZ)

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Polyrizon Ltd. - trades on the NASDAQ stock market under the symbol PLRZ.

As of March 9, 2026, PLRZ stock price declined to $12.98 with 7,954 million shares trading.

PLRZ has a beta of 0.44, meaning it tends to be less sensitive to market movements. PLRZ has a correlation of 0.00 to the broad based SPY ETF.

PLRZ has a market cap of $13.52 million. This is considered a Sub-Micro Cap stock.

PLRZ has underperformed the market in the last year with a price return of -73.8% while the SPY ETF gained +19.0%. However, in the short term, PLRZ had mixed performance relative to the market. It has outperformed in the last 3 months, returning +21.1% vs -0.4% return in SPY. But in the last 2 weeks, PLRZ shares have been beat by the market, returning -6.8% compared to an SPY return of -0.6%.

PLRZ support price is $12.25 and resistance is $13.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLRZ shares will trade within this expected range on the day.